Literature DB >> 10408714

Candidate autoantigens in multiple sclerosis.

S Schmidt1.   

Abstract

Multiple sclerosis is an inflammatory demyelinating CNS disease of putatively autoimmune origin. Novel models of experimental autoimmune encephalomyelitis (EAE) have demonstrated that T cells specific for various myelin and even nonmyelin proteins are potentially encephalitogenic. The encephalitogenic T cell response directed against different CNS antigens not only determines the lesional topography of CNS inflammation but also the composition of the inflammatory infiltrates. The heterogeneity of the lesional distribution seen in EAE might therefore be useful for the understanding of the various clinical subtypes seen in MS. In this review the possible candidate autoantigens in MS are discussed with special regard to the human T cell and B cell responses against various myelin and nonmyelin proteins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10408714     DOI: 10.1177/135245859900500303

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  23 in total

Review 1.  Role of HLA class II genes in susceptibility and resistance to multiple sclerosis: studies using HLA transgenic mice.

Authors:  David Luckey; Dikshya Bastakoty; Ashutosh K Mangalam
Journal:  J Autoimmun       Date:  2011-05-31       Impact factor: 7.094

Review 2.  The 2',3'-cAMP-adenosine pathway.

Authors:  Edwin K Jackson
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-21

Review 3.  Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines.

Authors:  Reinhard Hohlfeld; Hartmut Wekerle
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-11       Impact factor: 11.205

4.  MP4- and MOG:35-55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum.

Authors:  Stefanie Kuerten; Dilyana A Kostova-Bales; Lukas P Frenzel; Justine T Tigno; Magdalena Tary-Lehmann; Doychin N Angelov; Paul V Lehmann
Journal:  J Neuroimmunol       Date:  2007-07-25       Impact factor: 3.478

5.  The brain in vivo expresses the 2',3'-cAMP-adenosine pathway.

Authors:  Jonathan D Verrier; Travis C Jackson; Rashmi Bansal; Patrick M Kochanek; Ava M Puccio; David O Okonkwo; Edwin K Jackson
Journal:  J Neurochem       Date:  2012-03-20       Impact factor: 5.372

6.  Hematological effects of intermittent 2-hour infusions of cladribine in multiple sclerosis patients: a comparison of 2 dosage patterns.

Authors:  P Grieb; J Kamienowski; M Janisz; P Kuśnierczyk; J Kawiak; G Hoser; S J Chrapusta
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

Review 7.  Axonal degeneration in multiple sclerosis: the mitochondrial hypothesis.

Authors:  Kimmy G Su; Gary Banker; Dennis Bourdette; Michael Forte
Journal:  Curr Neurol Neurosci Rep       Date:  2009-09       Impact factor: 5.081

8.  Role of 2',3'-cyclic nucleotide 3'-phosphodiesterase in the renal 2',3'-cAMP-adenosine pathway.

Authors:  Edwin K Jackson; Delbert G Gillespie; Zaichuan Mi; Dongmei Cheng; Rashmi Bansal; Keri Janesko-Feldman; Patrick M Kochanek
Journal:  Am J Physiol Renal Physiol       Date:  2014-05-07

9.  Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis.

Authors:  Jofre Tenorio-Laranga; Francisco Coret-Ferrer; Buenaventura Casanova-Estruch; María Burgal; J Arturo García-Horsman
Journal:  J Neuroinflammation       Date:  2010-04-06       Impact factor: 8.322

10.  Replacement of a phenylalanine by a tyrosine in the active site confers fructose-6-phosphate aldolase activity to the transaldolase of Escherichia coli and human origin.

Authors:  Sarah Schneider; Tatyana Sandalova; Gunter Schneider; Georg A Sprenger; Anne K Samland
Journal:  J Biol Chem       Date:  2008-08-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.